Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer’s disease-Reference-Cited by-同舟云学术

Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer’s disease

Published:2024-06-05 Issue:1 Volume:15 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Ravikumar Sadhana^ORCID,Denning Amanda E.,Lim Sydney^ORCID,Chung Eunice^ORCID,Sadeghpour Niyousha^ORCID,Ittyerah Ranjit,Wisse Laura E. M.,Das Sandhitsu R.,Xie Long,Robinson John L.,Schuck Theresa,Lee Edward B.^ORCID,Detre John A.,Tisdall M. Dylan,Prabhakaran Karthik,Mizsei Gabor,de Onzono Martin Maria Mercedes Iñiguez,Arroyo Jiménez Maria del Mar^ORCID,Mũnoz Monica,Marcos Rabal Maria del Pilar^ORCID,Cebada Sánchez Sandra^ORCID,Delgado González José Carlos,de la Rosa Prieto Carlos,Irwin David J.,Wolk David A.,Insausti Ricardo,Yushkevich Paul A.^ORCID

Abstract

AbstractOur current understanding of the spread and neurodegenerative effects of tau neurofibrillary tangles (NFTs) within the medial temporal lobe (MTL) during the early stages of Alzheimer’s Disease (AD) is limited by the presence of confounding non-AD pathologies and the two-dimensional (2-D) nature of conventional histology studies. Here, we combine ex vivo MRI and serial histological imaging from 25 human MTL specimens to present a detailed, 3-D characterization of quantitative NFT burden measures in the space of a high-resolution, ex vivo atlas with cytoarchitecturally-defined subregion labels, that can be used to inform future in vivo neuroimaging studies. Average maps show a clear anterior to poster gradient in NFT distribution and a precise, spatial pattern with highest levels of NFTs found not just within the transentorhinal region but also the cornu ammonis (CA1) subfield. Additionally, we identify granular MTL regions where measures of neurodegeneration are likely to be linked to NFTs specifically, and thus potentially more sensitive as early AD biomarkers.

Funder

U.S. Department of Health & Human Services | NIH | National Institute on Aging

This work as also supported in part by MultiPark - A Strategic Research Area at Lund University and a UCLM research grant to the Human Neuroanatomy Laboratory.

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41467-024-49205-0.pdf

Reference70 articles.

1. Bobinski, M. et al. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 414–420 (1997).

2. Flores, R. et al. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer’s disease. Alzheimer’s Dement. 16, 843–852 (2020).

3. Gunten, A. V. et al. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer’s disease. Neurobiol. Aging 27, 270–277 (2006).

4. Thaker, A. A. et al. Entorhinal cortex: Antemortem cortical thickness and postmortem neurofibrillary tangles and amyloid pathology. Am. J. Neuroradiol. 38, 961–965 (2017).

5. Braak, H. & Braak, E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. normal morphology and lamina-specific pathology in alzheimer’s disease. Acta Neuropathol. 68, 325–332 (1985).